Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...

The research team at King’s College London, led by Dr. Heather Bax, explored the potential of a different antibody called IgE. Unlike IgG, IgE interacts with different immune cells, ...